全文获取类型
收费全文 | 9107篇 |
免费 | 767篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 308篇 |
妇产科学 | 180篇 |
基础医学 | 1175篇 |
口腔科学 | 217篇 |
临床医学 | 807篇 |
内科学 | 1968篇 |
皮肤病学 | 294篇 |
神经病学 | 845篇 |
特种医学 | 407篇 |
外科学 | 1417篇 |
综合类 | 85篇 |
一般理论 | 2篇 |
预防医学 | 647篇 |
眼科学 | 168篇 |
药学 | 621篇 |
中国医学 | 22篇 |
肿瘤学 | 675篇 |
出版年
2023年 | 52篇 |
2022年 | 102篇 |
2021年 | 220篇 |
2020年 | 142篇 |
2019年 | 227篇 |
2018年 | 289篇 |
2017年 | 219篇 |
2016年 | 214篇 |
2015年 | 234篇 |
2014年 | 336篇 |
2013年 | 381篇 |
2012年 | 512篇 |
2011年 | 537篇 |
2010年 | 343篇 |
2009年 | 302篇 |
2008年 | 453篇 |
2007年 | 451篇 |
2006年 | 455篇 |
2005年 | 389篇 |
2004年 | 329篇 |
2003年 | 357篇 |
2002年 | 274篇 |
2001年 | 275篇 |
2000年 | 268篇 |
1999年 | 257篇 |
1998年 | 103篇 |
1997年 | 110篇 |
1996年 | 106篇 |
1995年 | 89篇 |
1994年 | 98篇 |
1993年 | 69篇 |
1992年 | 183篇 |
1991年 | 150篇 |
1990年 | 145篇 |
1989年 | 170篇 |
1988年 | 135篇 |
1987年 | 136篇 |
1986年 | 122篇 |
1985年 | 123篇 |
1984年 | 64篇 |
1983年 | 72篇 |
1982年 | 28篇 |
1981年 | 35篇 |
1980年 | 26篇 |
1979年 | 37篇 |
1978年 | 42篇 |
1977年 | 24篇 |
1976年 | 30篇 |
1973年 | 19篇 |
1972年 | 20篇 |
排序方式: 共有9901条查询结果,搜索用时 15 毫秒
101.
In view of the economic constraints in acquiring sophisticated equipments in service hospitals, a new suspension device for endolaryngeal surgery using anaesthetic laryngoscope and routinely available tonsillectomy instruments has been developed. This device is a modification of Ijadoula''s suspension laryngoscope.KEY WORDS: Suspension laryngoscope, Laryngeal endoscopy 相似文献
102.
Gonzalez HB 《Health care management (Philadelphia, Pa.)》1994,1(1):159-163
As designed, the Health Security Act will be dysfunctional to those in greatest need, as the majority of the population residing in the 20th Congressional District in Texas. These have limited education, work for low wages, and live in a general state of high poverty. The author identifies specific concerns regarding the adequacy of Clinton's proposal in meeting the needs of that population, and provides a supportive analysis for McDermott's "American Health Security Act," and the possible effect that its single-payer concept may have on the people in the border state of Texas. 相似文献
103.
Yamazaki Hiroshi; Mimura Mayumi; Oda Yoshimitsu; Gonzalez Frank J.; El-Bayoumy Karam; Chae Young-Heum; Guengerich F.Peter; Shimada Tsutomu 《Carcinogenesis》1994,15(3):465-470
In order to address the hypothesis that 6-aminochrysene (6-AC)is converted to genotoxic products by cytochrome P450 enzymesvia two activation pathways (N-hydroxylation and epoxidation),the activation of 6-AC and trans-l,2-dihydro-l,2-dihydroxy-6-aminochrysene(6-AC-diol) to genotoxic metabolites was examined in rat andhuman liver microsomal cytochrome P450 enzymes using Salmonellatyphimurium TA1535/pSK1002 and TA1535/pSK1002/pNM12 (NM2009)as tester strains. The latter bacteria, an O-acetyl-transferase-overexpressingstrain, was highly sensitive to metabolites derived from activationof 6-AC, but not those from 6-AC-diol, using liver microsomesfrom phenobarbital-treated rats or a reconstituted monooxygenasesystem containing P4502B1 or -2B2, thus suggesting the rolesof P450 and acetyltransferase systems in the activation process.6-AC-diol, on the other hand, was activated very efficientlyby liver microsomes prepared from ß-naphthoflavone-treatedrats or a reconstituted system containing P4501A1 or -1A2; theactivation reaction is considered to proceed through diol-epoxideformation. The contribution of rat P4501A enzymes towards activationof 6-AC-diol was confirmed by the inhibitory effects on theactivation process of -naphthoflavone, a specific inhibitorof P4501 A-related activities, and antibodies raised againstpurified P4501A1 and -1A2. In humans, P4501A2 was found to bethe major enzyme involved in the activation of 6-AC-diol togenotoxic metabolites while the parent compound 6-AC was activatedmainly by P4503A4. Experiments using recombinant P450 proteinsexpressed in human lymphoblastoid cells lines showed that humanP4501A1 could also activate 6-AC-diol to reactive metabolitesat almost the same rate measured with P4501A2. In addition,P4502B6 was found to efficiently catalyze the activation of6-AC to genotoxic metabolites, and P4503A4 was active in theactivation of 6-AC-diol as well as 6-AC. Addition of purifiedrat epoxide hydrolase to the incubation mixture containing purifiedrat P4501A1 or microsomes expressing human P4501A1 caused inhibitionof activation of 6-AC-diol. These results suggest the existenceof different enzymatic activation pathways for 6-AC and 6-AC-diol.The former carcinogen may be N-hydroxylated principally by P4502Benzymes in rats and P4503A4 and -2B6 in humans and activationto its ultimate metabolites may proceed through esterificationof the N-hydroxy metabolites by an N-acetyltransferase. The6-AC-diol is metabolized to its ultimate diolepoxide productby P4501A enzymes in rat and human liver microsomes. P4503A4(humans) and P4503A2 (rats) may also contribute to some extentin the activation of 6-AC-diol, albeit at lower rates than thoseof P4501A enzymes. 相似文献
104.
Welsch C Welsch M Huelskamp L Gonzalez M Vanderploeg L 《International journal of oncology》1995,6(1):55-64
The purpose of this study was to assess the effects of the type of dietary fat [corn oil (controls), olive oil, linseed oil, primrose oil, canola oil and fish (Menhaden) oil] and the amount of dietary fat on the growth of MDA-MB231 human breast carcinomas in female athymic nude mice. The different types of fats examined in these studies differ widely in their omega-3, -6 and -9 fatty acid contents, fatty acid chain length and their degree of unsaturation. These fats were fed to the carcinoma bearing mice at 20% of the diet by weight and for 5 to 8 weeks. No significant effect of these diets on mouse body weight gains throughout the study was observed. Compared to the corn oil controls, none of the dietary fats significantly affected the growth of the human breast carcinomas in these animals, with the exception of fish oil which consistently and significantly (P<0.05 to P<0.001) suppressed carcinoma growth. DNA synthesis of the human breast carcinomas derived from the fish oil fed mice was assessed by BrdU and PCNA labeling indices and by H-3-thymidine autoradiographic analysis. Despite the fact that the carcinomas derived from the fish oil fed mice were significantly smaller than the carcinomas from the corn oil fed mice, there were no significant differences in any of these parameters of DNA synthesis between the two groups (corn oil and fish oil) of carcinomas. In contrast, in the human breast carcinomas derived from the fish oil fed mice, a significant increase (P<0.01 to P<0.001) in the rate of (125)IUrd loss (K-L/day) and a significant increase (P<0.05 to P<0.001) in the cell loss factor (phi) (phi=1-T-P/T-D) was observed, compared to carcinomas derived from corn oil fed mice. Analysis of the human breast carcinomas for TBARS, a measure of secondary products of lipid peroxidation, revealed that the carcinomas derived from the fish oil fed mice had significantly increased (P<0.001) concentrations of these products compared to carcinomas derived from corn oil fed mice. These results provide evidence that the suppression of growth of human breast carcinoma MDA-MB231 in athymic nude mice by dietary fish oil appears to be due primarily to an increase in the loss of cells from the carcinomas in lieu of a suppression of DNA synthesis, a phenomenon that may be due to the increased concentration of lipid peroxidation products in the tumor tissue. In the studies designed to examine the effect of the amount of fat on growth of MDA-MB231 human breast carcinomas in athymic nude mice, one group of mice was fed a high fat diet (corn oil, 29%) and a second group of mice was fed a low fat diet (corn oil, 1.8%). Both diets were fed at a restricted level, i.e., 65% of ad libitum. A third group of mice was fed a high fat diet (corn oil, 18.1%) ad libitum. The diets were formulated to assure that mice of each group consumed equal amounts of protein, vitamins, minerals and fiber; mice fed the high fat diets (ad libitum and restricted) consumed equal amounts of fat. Growth of the human breast carcinomas in mice fed the high fat and low fat restricted diets was not significantly different despite the large difference in fat consumption. Growth of the carcinomas in mice fed the high fat diet ad libitum was substantially greater than carcinoma growth in mice fed the restricted high fat diet (P<0.001) despite equal amounts of fat consumption. These results demonstrate that in an environment of energy (caloric) restriction, high levels of dietary fat will not enhance growth of MDA-MB231 human breast carcinomas in athymic nude mice, thus emphasizing the important role for energy (calories) in the enhancement of mammary (breast) tumorigenic processes by high fat diets. 相似文献
105.
In an in vitro preparation of the intact carotid body (CB) of the rabbit, adenosine (100 microM) inhibited hypoxia-induced catecholamine release by 25%. The specific A1 antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 1 microM) prevented the inhibition and increased the response to hypoxia further. In isolated chemoreceptor cells from the same species, adenosine inhibited voltage-dependent Ca2+ currents by 29% at 1 microM (concentration producing half-maximal inhibition, IC50 = 50 nM). This inhibition was mimicked by R(-)N6-(2-phenylisopropyl)-adenosine and 2-chloroadenosine (1 microM), two purinergic agonists poorly active at the intracellular ('P') site, and persisted in the presence of dipyridamole (a blocker of adenosine uptake; 1 microM) and was fully inhibited by 8-phenyltheophylline (10 microM). The A1 antagonists DPCPX (10 microM) and 8-cyclopentyl-1,3-dimethylxantine (0.1 microM) inhibited the effect of adenosine by 93% (IC50 = 0.14 microM) and 59%, respectively. The inhibition of the Ca2+ current (I(Ca)) was reduced by nisoldipine (an L-type Ca2+ channel antagonist) by nearly 50%, and was unaltered by omega-conotoxin GVIA, a blocker of N-type Ca2+ channels. Adenosine did not affect the voltage-dependent Na+ current (I(Na)) or K+ current (I(K)). We conclude that adenosine A1 receptors are located in chemoreceptor cells and mediate the inhibition of L-type Ca2+ channels and thereby the release of catecholamines produced by hypoxia. The data also indicate that endogenous adenosine acts as a physiological negative modulator of the chemoreceptor cell function. The previously reported excitatory action of adenosine on the activity of the sensory nerve of the CB is discussed in terms of a balance between the inhibition mediated by A1 receptors and the excitation mediated by A2 receptors. 相似文献
106.
Ahnaou A Basille M Gonzalez B Vaudry H Hamon M Adrien J Bourgin P 《The European journal of neuroscience》1999,11(11):4051-4058
In rats, rapid eye movement (REM) sleep can be elicited by microinjection of vasoactive intestinal polypeptide (VIP) into the oral pontine reticular nucleus (PnO). In the present study, we investigated whether this area could also be a REM-promoting target for a peptide closely related to VIP: the pituitary adenylyl cyclase-activating polypeptide (PACAP). When administered into the posterior part of the PnO, but not in nearby areas, of freely moving chronically implanted rats, PACAP-27 and PACAP-38 (0.3 and 3 pmol) induced a marked enhancement (60-85% over baseline) of REM sleep for 8 h that could be prevented by prior infusion of the antagonist PACAP-(6-27) (3 pmol) into the same site. Moreover, injections of PACAP into the centre of the posterior PnO resulted in REM sleep enhancement which could last for up to 11 consecutive days. Quantitative autoradiography using [125I]PACAP-27 revealed the presence in the PnO of specific binding sites with high affinity for PACAP-27 and PACAP-38 (IC50 = 2.4 and 3.2 nM, respectively), but very low affinity for VIP (IC50 > 1 microM). These data suggest that PACAP within the PnO may play a key role in REM sleep regulation, and provide evidence for long-term (several days) mechanisms involved in such a control. PAC1 receptors which have a much higher affinity for PACAP than for VIP might mediate this long-term action of PACAP on REM sleep. 相似文献
107.
108.
FK506-associated thrombotic microangiopathy: report of two cases and review of the literature 总被引:15,自引:0,他引:15
BACKGROUND: FK506 is a recently developed immunosuppressant that has been useful in improving the survival of transplanted organs. Among the numerous adverse side effects of FK506, thrombotic microangiopathy (TMA) stands out as an infrequent but severe complication. METHODS: We report two cases of FK506-associated TMA and review the 19 previous reported cases. RESULTS: From these 21 cases, the reported incidence of FK506-associated TMA is between 1% and 4.7%. It is more frequent in females, and the mean age at presentation is 47 years. Eighty-one percent of the cases occurred in patients with kidney allografts, and the remaining patients had liver, heart, or bone marrow transplants. Clinically, TMA was diagnosed at an average interval of 9.3 months from the time of transplantation. Patients may be asymptomatic or may present with the full-blown picture of hemolytic uremic syndrome. All patients had an elevated serum creatinine level but did not always show signs of hemolysis. Trough levels of FK506 were not predictive for the development of TMA, but generally a reduction of drug dose correlated with kidney function improvement and disappearance of the hemolytic picture. The renal allograft biopsy provided a conclusive diagnosis in all 17 cases in which this procedure was performed. Treatment, which mainly consisted of reduction or discontinuation of FK506, anticoagulation, and/or plasmapheresis with fresh-frozen plasma exchange, resolved TMA in most patients (57%). However, in one of these patients (5%), the graft was subsequently lost due to causes unrelated to TMA, such as acute or chronic rejection. Despite treatment, one patient (5%) lost the graft due to acute rejection and persistent TMA, and three other patients (14%) who had bone marrow, heart, and liver transplants, died of multiple organ failure, probably unrelated to TMA. In the remaining four patients (19%), response to treatment was not reported. CONCLUSIONS: TMA must be considered in organ transplant patients treated with FK506 whenever kidney function deteriorates, even in the absence of microangiopathic hemolytic anemia. Although TMA usually responds to treatment, it may, in rare cases, lead to loss of kidney function or even the patient's death. 相似文献
109.
110.
Dr. Rolando Grave de Peralta Menendez Sara L. Gonzalez Andino Bernd Lütkenhöner 《Brain topography》1996,9(2):117-124
Summary This paper introduces the concept of the resolution matrix as the basis for an objective theoretical comparison of distributed linear inverse solutions to the neuroelectromagnetic inverse problem. In particular, we describe how figures of merit derived from the resolution matrices can be represented graphically to evaluate merits and shortcomings of the different solutions. The use of the figures of merit is illustrated with two solutions that consider minimal a priori information about the generators: Classical Minimum Norm and Backus Gilbert. We recommend to start any analysis with the individual exploration of the resolution kernel for each grid point or at least for those points where the activity is likely to occur. This analysis might help in selecting the optimal inverse for the sources that are supposed to be active in the process under study.This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Klinische Forschergruppe Biomagnetismus and Biosignalanalyse). Partial support was received from Swiss National Foundation grant 4038-044081/1. 相似文献